Latest European patent oppositions filed by Pohlman, Sandra M.
Patent Number | Title | Applicant | Opposition Date |
---|---|---|---|
EP3384049 | Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age-Related Macular Degeneration Treated With Anti-Vegf | REGENERON PHARMACEUTICALS, INC. | 2024-04-30 |
EP3911354 | Aav-Mediated Gene Therapy Restoring The Otoferlin Gene | INSTITUT PASTEUR | 2024-04-19 |
EP3230316 | Treatment Of Age Related Macular Degeneration With A Small Active Choroidal Neovascularization Lesion | BAYER HEALTHCARE LLC | 2022-10-04 |
EP3464373 | Use Of Anti-Pd-1 Antibody In The Treatment Of Patients With Colorectal Cancer | BRISTOL-MYERS SQUIBB COMPANY | 2022-07-26 |
EP3498734 | Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer | MERCK SHARP & DOHME LLC | 2022-05-31 |
EP3401335 | Composition Comprising Antibody That Binds To Domain Ii Of Her2 And Acidic Variants Thereof | GENENTECH, INC. | 2022-03-22 |
EP3288980 | Treatment Of Pd-L1-Positive Melanoma Using An Anti-Pd-1 Antibody | BRISTOL-MYERS SQUIBB COMPANY | 2021-12-10 |
EP3330370 | Process For Cultivation Of Cho Cells | NOVARTIS AG | 2021-11-24 |
EP3616720 | Pharmaceutical Composition For Cancer Treatment | SHIONOGI & CO., LTD. | 2021-11-17 |
EP3570884 | Subcutaneous Her2 Antibody Formulations | GENENTECH, INC. | 2021-06-30 |
Top clients of Pohlman, Sandra M. filing patent oppositions